Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alirocumab and Rosuvastatin for Coronary Artery Disease
NCT03529253Phase 4Unknown
- Sponsor
- Kobe University
- Start
- Apr 2018
- Primary completion
- Sep 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of alirocumab in coronary artery disease (CAD), sponsored by Kobe University. Status: unknown.
02
Drugs
alirocumab
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03529253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03529253.